Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/08/056221
CTRI/2023/08/056221
Not yet recruiting
Phase 2

Clinical study to evaluate effect and safety of herbal formulation DRDC/2022/040 on Intragastric pHâ?? A randomized, open label, comparative, cross over, interventional, prospective study - NI

Dabur Research Development Centre Dabur India Limited0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dabur Research Development Centre Dabur India Limited
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dabur Research Development Centre Dabur India Limited

Eligibility Criteria

Inclusion Criteria

  • •1\.Healthy male and female subjects
  • •2\.Clinically normal physical findings at the time of screening visit
  • •3\.Laboratory values (CBC, CT, BT, Liver profile) within the normal range
  • •4\.Negative Urine pregnancy test at the time of screening for female participants
  • •5\.Ready to sign informed consent form and follow study procedure

Exclusion Criteria

  • •1\. Immunocompromised subjects or those suffering from any serious or debilitating medical condition;
  • •2\. Subjects with current drug, tobacco or alcohol abuse;
  • •3\. Subjects with diabetes/hypertension;
  • •4\. Subjects with presence of any disease/condition or physical defect which could preclude subjects from complying with study procedures.
  • •5\. Subjects receiving treatment with any medication which could alter or influence stomach acidity or study drug/placebo activity;
  • •6\. Subjects who investigator feels may be unreliable or unsuitable to participate in a clinical trial
  • •7\. Subject having participated in a clinical trial in the previous 30 days
  • •8\. Pregnant and Lactating females

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical exploratory study on the usefulness of hemodynamic preloading parameters using noninvasive cardiac output measuring device (ClearSight) for perioperative fluid management
JPRN-UMIN000025497Hokkaido Universtiy Graduate School of Medicine, Department of Gastroenterological SurgeryII18
Not yet recruiting
Not Applicable
Diabetes Management through AyurvedaHealth Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2023/04/051287Aayushi Mogra
Completed
Phase 3
To Study The Effectiveness Of Homoeopathic medicine in Reducing Serum IgE Levels In Chronic Allergic Rhinitis
CTRI/2021/01/030865DR NAGA NIVETHA P B50
Active, not recruiting
Phase 1
Clinical study to assess the efficacy and safety of gene therapy for the treatment of childhood cerebral adrenoleukodystrophyChildhood Cerebral Adrenoleukodystrophy (CCALD)MedDRA version: 18.0Level: PTClassification code 10051260Term: AdrenoleukodystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2011-001953-10-FRbluebird bio, Inc.15
Active, not recruiting
Phase 1
Clinical study to assess the efficacy and safety of gene therapy for the treatment of cerebral adrenoleukodystrophyCerebral Adrenoleukodystrophy (CALD)MedDRA version: 20.0Level: PTClassification code 10051260Term: AdrenoleukodystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2011-001953-10-DEbluebird bio, Inc.32